English | Español

Community

+ Community
Kacie Whaley | Sep 1, 2017

Rare disease therapy company, Shire, making executive changes
+ Community
Kacie Whaley | Aug 31, 2017

Moderate use of alcohol may reduce causes of death, study says
+ Community
Nicholas Gueguen | Aug 31, 2017

Pharmaceutical Researchers and Manufacturers Association stresses importance of immunizations for older Americans
+ Community
Nicholas Gueguen | Aug 31, 2017

Novartis names new chief digital officer
+ Community
Kacie Whaley | Aug 31, 2017

Alliance of Dedicated Cancer Centers honors congessman for cancer advocacy efforts
+ Community
Nicholas Gueguen | Aug 31, 2017

Registration underway for National Drug and Alcohol Facts Week
+ Community
Carol Ostrow | Aug 30, 2017

Study: HPV vaccine reduces secondary risk for childhood cancer survivors
+ Community
Nicholas Gueguen | Aug 30, 2017

Community health workers benefit Medicaid patients

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes